Effects of Anti-PD1 Adjuvant Checkpoint Blockade Immunotherapy on Atypical/Dysplastic Nevi | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Effects of Anti-PD1 Adjuvant Checkpoint Blockade Immunotherapy on Atypical/Dysplastic Nevi	Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, central nervous system malformation, hereditary disease, hereditary neoplastic syndrome, hereditary sensory and autonomic neuropathy, inherited neurodegenerative disorder, melanocytic neoplasm, melanocytic nevus, melanoma, melanoma, cutaneous malignant, susceptibility to, 2, neoplasm, nervous system disorder, neurodegenerative disease, neuroendocrine neoplasm, neuromuscular disease, peripheral nervous system disorder, polyneuropathy, primitive neuroectodermal tumor, skin disorder, skin neoplasm	Recruiting	Not stated	2026-01-26		NCT06599619

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
John Kirkwood	3
Melanoma Research Foundation	2
VeyTel Inc.	1

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
UPMC Hillman Cancer Center	Pittsburgh	United States	330